Kaboré, Charles
Ridde, Valéry
Chaillet, Nils
Yaya Bocoum, Fadima
Betrán, Ana Pilar
Dumont, Alexandre
Funding for this research was provided by:
French Muskoka Fund
CIHR Skin Research Training Centre (CIHR, ROH 115213)
Article History
Received: 31 January 2019
Accepted: 10 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: This trial protocol [CitationRef removed] was approved by the Ethics Committee of the University of Montreal Hospital Research Centre (CRCHUM) in Canada on March 26, 2014 (#13.356) (Additional file InternalRef removed) and by the National Ethics Committee in Burkina Faso on February 5, 2014 (#2014-02-016) (Additional file InternalRef removed). The DECIDE trial is registered on the Current Controlled Trials website: ISRCTN48510263. Participating hospitals were included on the basis of informed consent given by local authorities (hospital director and maternity service chief). The authorities were informed that (1) all hospitals are free to withdraw from the project at any time, (2) the intervention will be offered in hospitals in the control group at the end of the study if proven effective and (3) data collection will continue until the end of the study, even for hospitals that withdraw from the study. The collection of clinical data from hospital registers and medical records has been authorized by the hospital administrations and does not require patient consent.All information collected on patients, health professionals and health facilities is confidential.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.